The prevalence of prediagnostic Ro60 and Ro52 autoantibody and association with SRC is consistent with recent publication reporting that seropositivity against SSA (comprising autoantibodies against both Ro60 and Ro52 as a single test) at SSc diagnosis is associated with future risk of SSc/SRC [40]. The gene discussed is SRC; the disease is systemic sclerosis.